Wright Medical Group, Inc. (NASDAQ: WMGI) today announced that it will
host a conference call on Tuesday, May 1, 2012 at 3:30 p.m. Central Time
to discuss the Company's operating results for its first quarter ended
March 31, 2012. Operating results will be released at 3:00 p.m. Central
Time that day.
The live dial-in number for the call is 800-659-2032 (U.S.) /
617-614-2712 (International). The participant passcode for the call is
"Wright." A simultaneous webcast of the call will be available via
Wright Medical's corporate website at www.wmt.com.
The call will also be archived on this site for a minimum of 12 months.
A recording of the call will be available beginning at 5:30 p.m. Central
Time on May 1, 2012 through May 8, 2012. To hear this recording, dial
888-286-8010 (U.S.) / 617-801-6888 (International) and enter code
About Wright Medical
Wright Medical Group, Inc. is a global orthopaedic medical device
company and a leading provider of surgical solutions for the foot and
ankle market. The Company specializes in the design, manufacture and
marketing of devices and biologic products for extremity, hip and knee
repair and reconstruction. The Company has been in business for 60 years
and markets its products in over 60 countries worldwide. For more
information about Wright Medical, visit the Company's website at www.wmt.com.
CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS
The conference call and webcast may contain "forward-looking
statements" as defined under U.S. federal securities laws. These
statements reflect management's current knowledge, assumptions, beliefs,
estimates, and expectations and express management's current views of
future performance, results, and trends and may be identified by their
use of terms such as "anticipate," "believe," "could," "estimate,"
"expect," "intend," "may," "plan," "predict," "project," "will," and
other similar terms. Forward-looking statements are subject to a
number of risks and uncertainties that could cause our actual results to
materially differ from those described in the forward-looking statements.
Such risks and uncertainties include the impact of Wright's
settlement of the federal investigation into Wright's consulting
arrangements with orthopaedic surgeons relating to its hip and knee
products in the United States, including Wright's compliance with a
Deferred Prosecution Agreement through September 2012 and a Corporate
Integrity Agreement through September 2015, and those risks and
uncertainties discussed in our filings with the Securities and Exchange
Commission (including those described in Item 1A of our Annual Report on
Form 10-K for the year ended December 31, 2011, under the heading, "Risk
Factors"), including demand for and market acceptance of our new and
existing products; future actions of governmental authorities and other
third parties; tax measures; business development and growth
opportunities; product quality or patient safety issues; products
liability claims; enforcement of our intellectual property rights; the
geographic and product mix impact on our sales; retention of sales
representatives and independent distributors; inventory reductions or
fluctuations in buying patterns by wholesalers or distributors; ability
to realize the anticipated benefits of restructuring initiatives; and
impact of the commercial and credit environment on us and our customers
and suppliers. Readers should not place undue reliance on
Wright Medical Group, Inc.
Investors & Media:
Sr. Vice President, Chief Communications Officer